InvestSMART

Sonic Healthcare Limited (ASX: SHL) - Announcements

Current share price for SHL : $20.420 0.16 (0.78%)+

ASX company news and announcements for Sonic Healthcare Limited (SHL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Sonic Healthcare Limited (SHL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Sonic Healthcare Limited (SHL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Sonic Healthcare Limited (SHL)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$10,092 Release of Securities Subject to Voluntary Escrow 17 Jun 2026 4:08PM $19.815 $20.420 risen by 3.05%
$10,092 Completion of Sale and Leaseback of Brisbane Hub Laboratory 15 Jun 2026 4:22PM $19.940 $20.420 risen by 2.41%
$10,092 Change in substantial holding 13 Apr 2026 6:06PM $19.720 $20.420 risen by 3.55%
$10,092 Notification regarding unquoted securities - SHL 2 Apr 2026 4:34PM $19.980 $20.420 risen by 2.20%
$10,092 Change of Director's Interest Notice 9 Mar 2026 4:44PM $21.970 $20.420 fallen by 7.06%
$10,092 Notification regarding unquoted securities - SHL 4 Mar 2026 4:43PM $23.010 $20.420 fallen by 11.26%
$10,092 CEO Presentation Half Year Results to 31 December 2025 19 Feb 2026 8:50AM $21.240 $20.420 fallen by 3.86%
$10,092 Media Release Half Year Results to 31 December 2025 19 Feb 2026 8:49AM $21.240 $20.420 fallen by 3.86%
$10,092 Dividend/Distribution - SHL 19 Feb 2026 8:44AM $21.240 $20.420 fallen by 3.86%
$10,092 Half Yearly Report and Accounts 19 Feb 2026 8:42AM $21.240 $20.420 fallen by 3.86%
$10,092 Change in substantial holding 23 Jan 2026 6:49PM $23.340 $20.420 fallen by 12.51%
$10,092 Change of Director's Interest Notice 24 Nov 2025 4:34PM $23.540 $20.420 fallen by 13.25%
$10,092 Change of Director's Interest Notice 24 Nov 2025 4:33PM $23.540 $20.420 fallen by 13.25%
$10,092 Notification regarding unquoted securities - SHL 21 Nov 2025 4:23PM $23.090 $20.420 fallen by 11.56%
$10,092 Notification regarding unquoted securities - SHL 21 Nov 2025 4:21PM $23.090 $20.420 fallen by 11.56%
$10,092 Final Director's Interest Notice 21 Nov 2025 4:17PM $23.090 $20.420 fallen by 11.56%
$10,092 Change of Director's Interest Notice 21 Nov 2025 4:16PM $23.090 $20.420 fallen by 11.56%
$10,092 Initial Director's Interest Notice 21 Nov 2025 11:47AM $22.980 $20.420 fallen by 11.14%
$10,092 Notification of cessation of securities - SHL 21 Nov 2025 11:42AM $22.980 $20.420 fallen by 11.14%
$10,092 Results of Meeting 20 Nov 2025 2:12PM $22.700 $20.420 fallen by 10.04%
$10,092 2025 AGM CEO Presentations and Proxy Summary 20 Nov 2025 8:59AM $21.490 $20.420 fallen by 4.98%
$10,092 Chairman's Address to Shareholders 20 Nov 2025 8:55AM $21.490 $20.420 fallen by 4.98%
$10,092 Notification of cessation of securities - SHL 19 Nov 2025 4:40PM $21.490 $20.420 fallen by 4.98%
$10,092 Sonic Healthcare Sustainability Report 2025 17 Nov 2025 9:13AM $21.320 $20.420 fallen by 4.22%
$10,092 Change of Director's Interest Notice 22 Oct 2025 12:29PM $21.420 $20.420 fallen by 4.67%

1 - 25 of 833 results

Page 1 of 34

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.